rs121913232
|
|
Leukemia, Myelocytic, Acute
|
C |
0.710 |
CausalMutation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913232
|
|
Leukemia, Myelocytic, Acute
|
C |
0.710 |
CausalMutation
|
CLINVAR |
The role of kinase inhibitors in the treatment of patients with acute myeloid leukemia.
|
23714533 |
2013 |
rs121913232
|
|
Leukemia, Myelocytic, Acute
|
C |
0.710 |
CausalMutation
|
CLINVAR |
Mutational landscape of AML with normal cytogenetics: biological and clinical implications.
|
23261068 |
2013 |
rs121913232
|
|
Leukemia, Myelocytic, Acute
|
C |
0.710 |
CausalMutation
|
CLINVAR |
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.
|
23321257 |
2013 |
rs121913232
|
|
Leukemia, Myelocytic, Acute
|
C |
0.710 |
CausalMutation
|
CLINVAR |
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia.
|
23783394 |
2013 |
rs121913232
|
|
Leukemia, Myelocytic, Acute
|
C |
0.710 |
CausalMutation
|
CLINVAR |
Continuing aspirin in the perioperative patient.
|
22504186 |
2012 |
rs121913232
|
|
Leukemia, Myelocytic, Acute
|
C |
0.710 |
CausalMutation
|
CLINVAR |
Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.
|
22368270 |
2012 |
rs121913232
|
|
Leukemia, Myelocytic, Acute
|
C |
0.710 |
CausalMutation
|
CLINVAR |
[FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia].
|
19840437 |
2009 |
rs121913232
|
|
Leukemia, Myelocytic, Acute
|
|
0.710 |
GeneticVariation
|
BEFREE |
Recently, novel mutations within the activation loop were identified in patients with AML: deletion of isoleucine 836 (Ile836del) and an exchange of isoleucine 836 to methionine plus an arginine insertion (Ile836Met+Arg).
|
12663439 |
2003 |